L

Longeveron
D

LGVN

2.01000
USD
0.03
(1.52%)
Market Closed
Volume
8,534
EPS
-4
Div Yield
-
P/E
-0
Market Cap
29,821,918
OverviewSignalsIdeasNews
Related Instruments
    A
    AMC
    -0.09500
    (-2.08%)
    4.48000 USD
    B
    BB
    -0.04000
    (-1.66%)
    2.37000 USD
    G
    GME
    -0.790
    (-2.89%)
    26.560 USD
    N
    NOK
    -0.03000
    (-0.67%)
    4.45500 USD
    R
    RKT
    -0.050
    (-0.37%)
    13.610 USD
    S
    SNDL
    0.00500
    (0.26%)
    1.95500 USD
    More
News

Title: Longeveron

Sector: Healthcare
Industry: Biotechnology
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.